FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Clorazepate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 8 USDMF, 3 CEP/COS, 1 JDMF, 4 NDC API, 4 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

112 FDF Dossiers, 85 FDA Orange Book, 23 Europe, 3 Canada, 1 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 Gangwal Healthcare, 2 Kirsch Pharma, 2 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 1 CD Formulation, 3 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 1 Ideal Cures, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Keval Exports, 8 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 8 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 15 Lubricants & Glidants, 13 Disintegrants & Superdisintegrants, 10 Granulation, 10 Direct Compression, 10 Thickeners and Stabilizers, 7 Co-Processed Excipients, 6 Controlled & Modified Release, 5 Coating Systems & Additives, 5 Parenteral, 4 Taste Masking, 4 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 Film Formers & Plasticizers, 2 API Stability Enhancers, 2 Rheology Modifiers, 1 Topical, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 News #PharmaBuzz

3 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 6 Regulatory FDF Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
27/02/2026	Sanofi	France	SANOFI WINTHROP INDUSTRIE Gentilly FR	CEP 2008-170 - Rev 02	Dipotassium clorazepate monohydrate	2024-03-28	Valid	Chemical		898
27/02/2026	Honour Lab Limited	India	HONOUR LAB LIMITED Hyderabad IN	CEP 2024-134 - Rev 00	Dipotassium clorazepate monohydrate	2026-02-02	Valid	Chemical		898

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Clorazepate

Clorazepate

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers

8 USDMF

3 CEP/COS

1 JDMF

4 NDC API

4 Listed Suppliers

$ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

112 FDF Dossiers

85 FDA Orange Book

23 Europe

3 Canada

1 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

3 Gangwal Healthcare

2 Kirsch Pharma

2 Actylis

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

1 CD Formulation

3 DFE Pharma

1 Finar

5 Gangwal Chemicals

1 Ideal Cures

1 Ingredion Pharma Solutions

1 Kerry

2 Keval Exports

8 Microlex e.U

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

8 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Silverline Chemicals

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders

15 Lubricants & Glidants

13 Disintegrants & Superdisintegrants

10 Granulation

10 Direct Compression

10 Thickeners and Stabilizers

7 Co-Processed Excipients

6 Controlled & Modified Release

5 Coating Systems & Additives

5 Parenteral

4 Taste Masking

4 Emulsifying Agents

3 Chewable & Orodispersible Aids

2 Film Formers & Plasticizers

2 API Stability Enhancers

2 Rheology Modifiers

1 Topical

1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions

6 Regulatory FDF Prices

MARKET PLACE

2 APIs

TABLET;ORAL - 11.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 22.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 3.75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons